Search Ontology:
ChEBI
alpha-D-Galp-(1->4)-beta-D-Galp-(1->4)-alpha-D-GlcpNAc
- Term ID
- CHEBI:148176
- Synonyms
-
- alpha-D-galacto-hexopyranosyl-(1->4)-beta-D-galacto-hexopyranosyl-(1->4)-2-acetamido-2-deoxy-alpha-D-gluco-hexopyranose
- alpha-D-galactopyranosyl-(1->4)-beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-alpha-D-glucopyranose
- Gal(a1-4)Gal(b1-4)a-GlcNAc
- N-[(2S,3R,4R,5S,6R)-5-[(2S,3R,4R,5R,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-2,4-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide
- Definition
- An amino trisaccharide consisting of α-D-galactopyranose, β-D-galactopyranose and 2-acetamido-2-deoxy-α-D-glucopyranose residues joined in sequence by (1→4) glycosidic bonds.
- References
-
- glygen:G16636QX
- glytoucan:G16636QX
- Ontology
- ChEBI ( EBI )
Phenotype
Phenotype resulting from alpha-D-Galp-(1->4)-beta-D-Galp-(1->4)-alpha-D-GlcpNAc
Phenotype where environments contain alpha-D-Galp-(1->4)-beta-D-Galp-(1->4)-alpha-D-GlcpNAc
Phenotype modified by environments containing alpha-D-Galp-(1->4)-beta-D-Galp-(1->4)-alpha-D-GlcpNAc
Phenotype affecting alpha-D-Galp-(1->4)-beta-D-Galp-(1->4)-alpha-D-GlcpNAc
Human Disease Model